Long-lasting HIV prevention drug could be game changer — but who will pay?
Long-lasting HIV prevention drug could be game changer — but who will pay? Injectable antiviral cabotegravir provides stronger protection than oral pill, but researchers fear it could be too expensive to make a difference for countries with the greatest disease burden. T.V. Padma Twitter Facebook Email Coloured transmision electron micrograph (TEM) of HIV particles (pink) […]
Long-lasting HIV prevention drug could be game changer — but who will pay? Read More »